" class="no-js "lang="en-US"> Cardiovascular Archives - Medtech Alert
Wednesday, April 10, 2024

Sort by:

Date

Top Post

New Initiative Aims to Reverse the Alarming Rise in Cardiovascular Deaths

The number of cardiovascular deaths is on the rise again after a decades-long decline. As […]

Acticor Biotech Announces the Enrollment of the First US Patient in Its Phase 2/3 Study ACTISAVE for the Treatment of Stroke

ACTICOR BIOTECH (ISIN: FR0014005OJ5 – ALACT), a clinical-stage biotechnology company developing innovative drugs for the […]

Rivus Pharmaceuticals Closes $132 Million Series B Financing to Advance HU6 for the Treatment of Obesity and Cardio-Metabolic Disorders

Rivus Pharmaceuticals Inc., a clinical-stage biopharmaceutical company dedicated to improving cardio-metabolic health, today announced the […]

Advanced NanoTherapies' SirPlux Duo Drug-Coated Balloon Receives FDA Breakthrough Designation for Small Vessel Coronary Artery Disease

Advanced NanoTherapies, Inc., a privately-held medical device company committed to solving vascular disease’s most significant […]

Prolifagen Therapeutics Appoints M. Alexander Shaw, PhD, as Chief Executive Officer

Prolifagen Therapeutics, a biotech startup developing medicines for cardiac regeneration, has appointed M. Alexander Shaw, PhD, […]

Cue Health Appoints David Tsay, MD, PhD, as Chief Medical Officer

Cue Health Inc. (“Cue”) ( Nasdaq: HLTH), a healthcare technology company, today announced that it has appointed David […]

Biosense Webster Launches the OCTARAY™ Mapping Catheter with TRUEref™ Technology

Biosense Webster, Inc., part of Johnson & Johnson MedTech[†], today announced the release of the […]

Novo Nordisk to Acquire Forma Therapeutics and Expand Presence in Sickle Cell Disease and Rare Blood Disorders

Novo Nordisk and Forma Therapeutics, Holdings Inc. (Nasdaq: FMTX) today announced that they have entered […]

Single Pill Proves More Effective at Preventing Further Heart Attack or Stroke

A single pill containing medication to lower cholesterol and blood pressure and stop clotting is […]

Novo Holdings Leads $50 Million Investment in MedGenome to Accelerate Expansion Into New Markets and Deepen Product Offerings

MedGenome, the leading genetic diagnostics, research, and data company in South Asia, announced today a […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more